Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EMPAGLIFLOZIN Cause Mental status changes? 46 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 46 reports of Mental status changes have been filed in association with EMPAGLIFLOZIN (Jardiance). This represents 0.1% of all adverse event reports for EMPAGLIFLOZIN.

46
Reports of Mental status changes with EMPAGLIFLOZIN
0.1%
of all EMPAGLIFLOZIN reports
8
Deaths
39
Hospitalizations

How Dangerous Is Mental status changes From EMPAGLIFLOZIN?

Of the 46 reports, 8 (17.4%) resulted in death, 39 (84.8%) required hospitalization, and 7 (15.2%) were considered life-threatening.

Is Mental status changes Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EMPAGLIFLOZIN. However, 46 reports have been filed with the FAERS database.

What Other Side Effects Does EMPAGLIFLOZIN Cause?

Diabetic ketoacidosis (3,644) Fungal infection (1,941) Blood glucose increased (1,797) Euglycaemic diabetic ketoacidosis (1,769) Weight decreased (1,661) Urinary tract infection (1,439) Ketoacidosis (1,411) Dizziness (1,372) Nausea (1,333) Vomiting (1,201)

What Other Drugs Cause Mental status changes?

BACLOFEN (600) GABAPENTIN (427) METFORMIN (371) CLOZAPINE (361) PREDNISONE (357) DUPILUMAB (354) METHOTREXATE (352) TACROLIMUS (339) LENALIDOMIDE (316) MORPHINE (310)

Which EMPAGLIFLOZIN Alternatives Have Lower Mental status changes Risk?

EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\METFORMIN EMPAGLIFLOZIN vs EMSAM EMPAGLIFLOZIN vs EMTRICITABINE

Related Pages

EMPAGLIFLOZIN Full Profile All Mental status changes Reports All Drugs Causing Mental status changes EMPAGLIFLOZIN Demographics